U.S. Markets closed

Blackhawk Growth Corp. (BLRZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02780.0000 (0.00%)
At close: 9:45AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0278
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0278 - 0.0278
52 Week Range0.0001 - 0.0800
Avg. Volume4,617
Market Cap5.709M
Beta (5Y Monthly)0.79
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Blackhawk’s Investee NuWave Foods Signs Technology Evaluation and License Option Agreement With EnWave Corporate

    Blackhawk Growth Corp. (CSE: BLR; Franfurt:0JJ; US-OTC: BLRZF) (the “Corporation” or “Blackhawk”), is pleased to provide a corporate update on its latest investment NuWave Foods Inc. (“Nu Wave”). NuWave recently signed a “Technology Evaluation and License Option Agreement” (“TELOA”) with EnWave Corporation (“EnWave”) (ENW.V). During the term of the TELOA, NuWave will have full access to EnWave’s patented drying technology and access to their food engineers for product development and technology evaluation purposes.

  • GlobeNewswire

    Blackhawk Signs Distribution Agreement to Sell COVID-19 Antibody Test Kits in the United States

    In response to more politicians demanding increased testing and recent comments from Governor Andrew Cuomo of New York stating, “The more testing, the more open the economy”, Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ; US-OTC:BLRZF) (the “Corporation” or “Blackhawk”), is pleased to announce that it has signed a non-exclusive distribution agreement with a private arms-length California-based entity to distribute Innovita’s 2019-nCoV Ab testing kits used in the detection of antibodies associated with COVID-19. The distributor will be responsible for their own costs associated with the distribution of the test kits to healthcare clinics, government organizations, pharmacies and retailers in the US, and all profits will be divided evenly between Blackhawk and the distributor.

  • GlobeNewswire

    Blackhawk’s Initial Order of 1,000 COVID-19 Antibody Testing Kits Delivered to Healthcare Clinic in Rocklin, California – 5 Days After Initial Order Was Submitted

    Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ; US-OTC:BLRZF) (the “Corporation” or “Blackhawk”), is pleased to announce that after submitting its initial order on May 1, 2020 for 1,000 Innovita manufactured COVID-19 antibody testing kits, the Company can confirm that the kits arrived and were delivered to the healthcare clinic in Rocklin, California on May 6, 2020. “This is the start we were hoping for,” said Frederick Pels, CEO of Blackhawk.